| Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations European Network of National Networks studying Gene-Environment Interactions ... Schizophrenia bulletin 40 (4), 729-736, 2014 | 273 | 2014 |
| Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. ENONNSGEII Schizophrenia Schizophr Bull 40, 729-736, 0 | 273* | |
| Right care, first time: a highly personalised and measurement‐based care model to manage youth mental health IB Hickie, EM Scott, SP Cross, F Iorfino, TA Davenport, AJ Guastella, ... Medical Journal of Australia 211, S3-S46, 2019 | 128 | 2019 |
| Inflammatory molecular signature associated with infectious agents in psychosis LN Hayes, EG Severance, JT Leek, KL Gressitt, C Rohleder, JM Coughlin, ... Schizophrenia bulletin 40 (5), 963-972, 2014 | 118 | 2014 |
| Therapeutic potential of cannabinoids in psychosis FM Leweke, JK Mueller, B Lange, C Rohleder Biological psychiatry 79 (7), 604-612, 2016 | 117 | 2016 |
| Cannabidiol as a potential new type of an antipsychotic. A critical review of the evidence C Rohleder, JK Müller, B Lange, FM Leweke Frontiers in Pharmacology 7, 222052, 2016 | 110 | 2016 |
| Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders C Schaefer, F Enning, JK Mueller, JM Bumb, C Rohleder, TM Odorfer, ... European archives of psychiatry and clinical neuroscience 264, 459-463, 2014 | 78 | 2014 |
| The functional networks of prepulse inhibition: neuronal connectivity analysis based on FDG-PET in awake and unrestrained rats C Rohleder, D Wiedermann, B Neumaier, A Drzezga, L Timmermann, ... Frontiers in behavioral neuroscience 10, 148, 2016 | 67 | 2016 |
| IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia EG Severance, KL Gressitt, A Alaedini, C Rohleder, F Enning, JM Bumb, ... Brain, behavior, and immunity 44, 148-158, 2015 | 67 | 2015 |
| Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans VL Chadwick, C Rohleder, D Koethe, FM Leweke Current Opinion in Psychiatry 33 (1), 20-42, 2020 | 57 | 2020 |
| Role of the endocannabinoid system in the pathophysiology of schizophrenia: implications for pharmacological intervention FM Leweke, JK Mueller, B Lange, S Fritze, CE Topor, D Koethe, ... CNS drugs 32, 605-619, 2018 | 50 | 2018 |
| Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism MW Meinhardt, S Pfarr, G Fouquet, C Rohleder, ML Meinhardt, ... Science Advances 7 (47), eabh2399, 2021 | 49 | 2021 |
| Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivity O Grimm, M Löffler, S Kamping, A Hartmann, C Rohleder, M Leweke, ... European Neuropsychopharmacology 28 (7), 841-849, 2018 | 49 | 2018 |
| Differential melatonin alterations in cerebrospinal fluid and serum of patients with major depressive disorder and bipolar disorder JM Bumb, F Enning, JK Mueller, T van der List, C Rohleder, P Findeisen, ... Comprehensive psychiatry 68, 34-39, 2016 | 47 | 2016 |
| Familial abnormalities of endocannabinoid signaling in schizophrenia D Koethe, F Pahlisch, M Hellmich, C Rohleder, JK Mueller, ... The World Journal of Biological Psychiatry 20 (2), 117-125, 2019 | 42 | 2019 |
| Oleoylethanolamide and human neural responses to food stimuli in obesity M Grosshans, E Schwarz, JM Bumb, C Schaefer, C Rohleder, C Vollmert, ... JAMA psychiatry 71 (11), 1254-1261, 2014 | 39 | 2014 |
| Cannabidiol and amisulpride improve cognition in acute schizophrenia in an explorative, double-blind, active-controlled, randomized clinical trial FM Leweke, C Rohleder, CW Gerth, M Hellmich, R Pukrop, D Koethe Frontiers in pharmacology 12, 614811, 2021 | 37 | 2021 |
| Association of anandamide with altered binocular depth inversion illusion in schizophrenia AR Reuter, JM Bumb, JK Mueller, C Rohleder, F Pahlisch, F Hanke, ... The World Journal of Biological Psychiatry 18 (6), 483-488, 2017 | 34 | 2017 |
| Effects of cannabidiol and delta-9-tetrahydrocannabinol on emotion, cognition, and attention: a double-blind, placebo-controlled, randomized experimental trial in healthy … T Woelfl, C Rohleder, JK Mueller, B Lange, A Reuter, AM Schmidt, ... Frontiers in psychiatry 11, 576877, 2020 | 31 | 2020 |
| Neural correlates of sensorimotor gating: a metabolic positron emission tomography study in awake rats C Rohleder, F Jung, H Mertgens, D Wiedermann, M Sué, B Neumaier, ... Frontiers in Behavioral Neuroscience 8, 178, 2014 | 31 | 2014 |
